These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 6767967

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Intramuscular injections of PGE1 in patients with severe claudication].
    Corsi M, Laurora G, Cesarone MR.
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):59-63. PubMed ID: 10658447
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Benzbromarone therapy in management of refractory gout.
    Kumar S, Ng J, Gow P.
    N Z Med J; 2005 Jun 24; 118(1217):U1528. PubMed ID: 15980902
    [Abstract] [Full Text] [Related]

  • 45. The effect of exogenous phosphocreatine on maximal walking distance, blood rheology, platelet aggregation, and fibrinolysis in patients with intermittent claudication.
    Panchenko E, Dobrovolsky A, Rogoza A, Sorokin E, Ageeva N, Markova L, Titaeva E, Anuchin V, Karpov Y, Saks V.
    Int Angiol; 1994 Mar 24; 13(1):59-64. PubMed ID: 8077800
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Double blind trial of nialamide in intermittent claudication. Effects on blood cholesterol, fibrinolysis and 5-hydroxytryptamine.
    Tsapogas MJ, Flute PT.
    Vasc Dis; 1964 Sep 24; 1(5):249-51. PubMed ID: 4867905
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar 24; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attinà T, Dell'Arte S, Sarnataro F.
    Int J Clin Pharmacol Ther; 1999 Jul 24; 37(7):347-51. PubMed ID: 10442509
    [Abstract] [Full Text] [Related]

  • 54. Hemostasis and fibrinolysis in patients with intermittent claudication: effects of prostaglandin E1.
    Weiss C, Regele S, Velich T, Bärtsch P, Weiss T.
    Prostaglandins Leukot Essent Fatty Acids; 2000 Nov 24; 63(5):271-7. PubMed ID: 11090253
    [Abstract] [Full Text] [Related]

  • 55. [The behavior of some metabolic and instrumental parameters in diabetics with arteriopathy of the lower extremities treated with increasing doses of glucuronyl-glycosaminoglycano-sulfate].
    Marigo S.
    Clin Ter; 1980 Jun 15; 93(5):503-18. PubMed ID: 7428314
    [No Abstract] [Full Text] [Related]

  • 56. [Drug modification of a risk factor of thrombosis in patients with varicosis].
    Haas S, von Eckstädt AV, Lill G, Weichenmeier I, Blümel G.
    Fortschr Med; 1982 Aug 12; 100(30):1418-22. PubMed ID: 7129301
    [No Abstract] [Full Text] [Related]

  • 57. [Possible effect of Désuric on reported deafness in hyperuremic patients. Apropos of 30 cases].
    Oudot J, Martin H.
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1979 Nov 12; 28(9):643-4. PubMed ID: 162352
    [No Abstract] [Full Text] [Related]

  • 58. [Experiences with new Cosaldon forms].
    Dammann C.
    Med Klin; 1969 Feb 21; 64(8):344-8. PubMed ID: 5783023
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.